UZCHS-UCSF CTRC Zengeza Clinical Research Site
Harare, Zimbabwe
NCT Number: NCT03049176
This is a prospective, non-randomized, open-label study to look at the uptake, adherence to, and impact of pre-exposure prophylaxis (PrEP), antiretroviral therapy (ART), semen washing, and vaginal insemination to prevent HIV among HIV-discordant couples attempting conception in Zimbabwe.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Observational
Harare, Zimbabwe
The reproductive needs of HIV-discordant couples who desire pregnancy represent an urgent public health problem that has been neglected in HIV prevention research. In Zimbabwe , and across sub-Saharan Africa, the vast majority of HIV-infected individuals are adults of reproductive age. Pregnancy and the desire for children are common among HIV-infected individuals, and HIV-discordant couples face a difficult choice between attempting pregnancy and risking HIV transmission to their partners. Recent surveys have found that 30-50% of HIV-infected individuals in sub-Saharan Africa are involved in stable, HIV-discordant relationships, and HIV transmission within married, cohabitating HIV-discordant couples accounts for 44-60% of new HIV infections in some regions of sub-Saharan Africa. While knowledge of HIV discordance can lead to increased condom use, many discordant couples have unprotected intercourse often motivated by the desire to conceive. Currently, HIV discordant couples who attempt to conceive place themselves at considerable risk of transmission. This research study aims to help promote couples' rights to conceive while at the same time decreasing the risk of HIV transmission.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For all couples:
For HIV-uninfected members of the couple
For HIV-infected members of the couple
Exclusion criteria
oral, daily Truvada for HIV-negative participants
Other names: emtricitabine/tenofovir disoproxil fumarate
oral daily antiretrovirals and frequent viral load monitoring for HIV-positive participant
Other names: ART
collection of semen from an HIV-positive man, processing semen to remove HIV, followed by intrauterine insemination
collection of semen from an HIV-negative man, followed by intravaginal insemination
Time frame: 12 months
proportion of couples choosing the strategy
Time frame: 12 months
proportion of couples remaining on strategy; reports of satisfaction
Time frame: 12 months
proportion of couples with high adherence to strategy
Time frame: 12 months
incidence of HIV
Time frame: 12 months
incidence of pregnancy
Time frame: 12 months
costs
Time frame: 12 months
model the cost effectiveness of various combinations of safer conception strategies
University of California, San Francisco
Other
The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples
Acronym: SAFER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03048422
Blood-Borne Infections, Communicable Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT05388474
Blood-Borne Infections, Communicable Diseases
Los Angeles, California, United States
View Trial DetailsNCT03284710
Blood-Borne Infections, Communicable Diseases
Maputo, Mozambique
View Trial DetailsNCT02591420
Blood-Borne Infections, Communicable Diseases
Kericho, Kenya
View Trial Details